thiosulfates has been researched along with Peritoneal Carcinomatosis in 16 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two-route chemotherapy of cisdiamminedichloroplatinum (CDDP) and sodium thiosulfate (STS) was performed in 32 patients with peritonitis carcinomatosa, originated from 21 gastric cancers, 4 colorectal cancers, 3 pancreatic cancers, 2 leiomyosarcomas of small intestine, one ovarian cancer and one bile duct cancer." | 3.67 | [Clinical efficacy of two-route chemotherapy with CDDP and STS in patients with peritonitis carcinomatosa]. ( Hirao, E; Kobayashi, M; Kuwahara, A; Nakashima, K; Saito, T; Shigemitsu, Y, 1989) |
| "To treat carcinomatosis, we use cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC)." | 1.40 | Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. ( Levine, EA; Loggie, BL; Russell, GB; Shen, P; Stewart, JH; Votanopoulos, KI, 2014) |
| ""Two-route chemotherapy" (TRC) using cis-diamminedichloroplatinum(II) (DDP) and its antidote, sodium thiosulfate (STS), combined with the angiotensin II (AT-II)-induced hypertension method was evaluated for its efficacy against peritoneally disseminated tumors in rats." | 1.28 | "Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats. ( Aoki, K; Baba, T; Hasuda, K; Kobayashi, H; Kuroiwa, T; Taniguchi, S, 1989) |
| " This study demonstrates a pharmacokinetic advantage of intraperitoneal chemotherapy with cDDP and an effectiveness against peritoneal carcinosis from various malignancies with minimal systemic toxicity." | 1.27 | [Effective treatment of peritoneal carcinosis by intraperitoneal cis-diamminedichloroplatinum (c-DDP) administration with systemic sodium thiosulfate protection. Clinical results and pharmacokinetics]. ( Ehninger, G; Jakob, F; Rückle, H; Wilms, K, 1986) |
| " This pilot study demonstrates a pharmacokinetic advantage of ip chemotherapy with c-DDP and an effectiveness against peritoneal carcinosis." | 1.27 | [Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics]. ( Ehninger, G; Haag, C; Rückle, H; Wilms, K, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levine, EA | 1 |
| Stewart, JH | 1 |
| Shen, P | 1 |
| Russell, GB | 1 |
| Loggie, BL | 1 |
| Votanopoulos, KI | 1 |
| Iwamoto, Y | 2 |
| Kawano, T | 1 |
| Uozumi, J | 1 |
| Aoki, K | 2 |
| Baba, T | 5 |
| Taniguchi, S | 2 |
| Howell, SB | 2 |
| Pfeifle, CL | 1 |
| Wung, WE | 1 |
| Olshen, RA | 1 |
| Lucas, WE | 1 |
| Yon, JL | 1 |
| Green, M | 1 |
| Furukawa, T | 2 |
| Kumai, K | 2 |
| Kubota, T | 2 |
| Hirahata, S | 1 |
| Shimizu, H | 1 |
| Matsui, H | 1 |
| Takahara, T | 1 |
| Aizawa, K | 1 |
| Shibata, S | 2 |
| Shimada, A | 2 |
| Kusano, H | 1 |
| Miyashita, K | 1 |
| Matsuo, T | 1 |
| Jibiki, M | 1 |
| Nakagoe, T | 1 |
| Miura, T | 1 |
| Tomita, M | 1 |
| Kurihara, N | 1 |
| Yamamoto, T | 1 |
| Saikawa, Y | 1 |
| Ogawa, S | 1 |
| Murayama, Y | 1 |
| Abe, R | 1 |
| Akiyoshi, T | 1 |
| Canal, P | 1 |
| de Forni, M | 1 |
| Chatelut, E | 1 |
| Chevreau, C | 1 |
| Johnson, NP | 1 |
| Houin, G | 1 |
| Bugat, R | 1 |
| Kobayashi, H | 1 |
| Hasuda, K | 1 |
| Kuroiwa, T | 1 |
| Kuwahara, A | 1 |
| Saito, T | 1 |
| Nakashima, K | 1 |
| Shigemitsu, Y | 1 |
| Hirao, E | 1 |
| Kobayashi, M | 1 |
| Markman, M | 1 |
| Cleary, S | 1 |
| Pfeifle, CE | 1 |
| Rückle, H | 2 |
| Ehninger, G | 2 |
| Jakob, F | 1 |
| Wilms, K | 2 |
| Haag, C | 1 |
| Yonemura, Y | 1 |
| Matsuda, Y | 1 |
| Miyata, R | 1 |
| Hashimoto, T | 1 |
| Takashima, T | 1 |
| Sawa, T | 1 |
| Takegawa, S | 1 |
| Miyazaki, I | 1 |
1 trial available for thiosulfates and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers.
Topics: Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Transformed; Cisp | 1993 |
15 other studies available for thiosulfates and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplast | 2014 |
"Two-route chemotherapy" using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Injections, Intraperiton | 1984 |
"Two route chemotherapy" using cis-diamminedichloro-platinum(II) and its antidote, sodium thiosulfate, for peritoneally disseminated cancer in rats.
Topics: Animals; Antidotes; Cisplatin; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Liver | 1982 |
Intraperitoneal cisplatin with systemic thiosulfate protection.
Topics: Adult; Aged; Ascites; Cisplatin; Drug Therapy, Combination; Female; Humans; Kinetics; Male; Middle A | 1982 |
[Continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cis | 1993 |
[Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
Topics: Adult; Aged; Animals; Cisplatin; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritonea | 1993 |
'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer.
Topics: Adult; Aged; Animals; Antidotes; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Dogs; Female; Human | 1990 |
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate.
Topics: Adenocarcinoma; Antidotes; Cisplatin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug T | 1989 |
"Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats.
Topics: Angiotensin II; Animals; Antidotes; Blood Pressure; Carcinoma, Transitional Cell; Cisplatin; Dose-Re | 1989 |
[Clinical efficacy of two-route chemotherapy with CDDP and STS in patients with peritonitis carcinomatosa].
Topics: Adult; Aged; Aged, 80 and over; Antidotes; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Fe | 1989 |
High-dose intracavitary cisplatin with intravenous thiosulfate. Low incidence of serious neurotoxicity.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Ear Diseases; Fe | 1985 |
[Effective treatment of peritoneal carcinosis by intraperitoneal cis-diamminedichloroplatinum (c-DDP) administration with systemic sodium thiosulfate protection. Clinical results and pharmacokinetics].
Topics: Adult; Aged; Antidotes; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dose-Response Relations | 1986 |
[Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics].
Topics: Adenocarcinoma; Ascites; Carcinoma; Catheterization; Cisplatin; Female; Humans; Kinetics; Male; Meso | 1985 |
[The effect of continuous hyperthermic peritoneal perfusion using high-dose cis-diamminedichloroplatinum for peritoneal dissemination of gastric cancers].
Topics: Adult; Aged; Cisplatin; Female; Hot Temperature; Humans; Male; Middle Aged; Perfusion; Peritoneal Ca | 1985 |
[Two-route chemotherapy using a combination of anticancer agents and antidotes].
Topics: Animals; Cisplatin; Drug Therapy, Combination; Female; Liver Neoplasms, Experimental; Lung Neoplasms | 1985 |